Antimicrobial resistance (AMR) is a major global health threat. Aidian takes part in supporting antimicrobial stewardship and sustainable us...

1 czerwca 2022
Wiadomości, AMR

The new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) entered into application on 26 May 2022. The new regulation will...

31 maja 2022
Wiadomości, Nowości produktowe

We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjerna...

2 maja 2022
Wiadomości

Viruses are major causes of upper respiratory tract infections (URTIs). Yet, antibiotics are commonly prescribed for URTIs. Even if, the flu...

28 kwietnia 2022
Wiadomości, Nowości produktowe

We have updated our website with a new sustainability section. You can now find more information about sustainability at Aidian, our commitm...

26 kwietnia 2022
Wiadomości

Emerging evidence show that among patients with COVID-19, the risk of death of diabetes is 50% higher than those without diabetes, especiall...

29 marca 2022
Wiadomości, Nowości produktowe, COVID-19

Non-invasive point of care (POC) faecal immunochemical tests (FITs) aid in triaging both asymptomatic and symptomatic patients for colonosco...

16 marca 2022
Wiadomości, Nowości produktowe

The new re-designed QuikRead go workstation is now available! It is designed to ensure effortless testing with the QuikRead go -system and i...

3 marca 2022
Wiadomości, Nowości produktowe